ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,511Medicare Part D Prescriptions Filled, Including Refills

Rank: 43 out of 1111

$936K Total Retail Price of All Prescriptions

Rank: 53 out of 1111

730 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 730 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 730 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 13,034 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 1,022 632 S3 1 1
LISINOPRIL 764 628 2 2
OMEPRAZOLE 601 401 3 4
SIMVASTATIN 514 404 4 5
CITALOPRAM HBR 482 370 5 14
FUROSEMIDE 472 408 6 6
AMLODIPINE BESYLATE 436 377 7 7
PRAVASTATIN SODIUM 418 280 8 17
LEVOTHYROXINE SODIUM 367 299 9 3
GABAPENTIN 352 248 10 10
METFORMIN HCL 346 227 11 8
METOPROLOL SUCCINATE 326 261 12 20
POTASSIUM CHLORIDE 318 262 13 9
MELOXICAM 302 204 14 18
METOPROLOL TARTRATE 289 255 15 12
HYDROCHLOROTHIAZIDE 257 196 16 11
TRAMADOL HCL 256 144 17 13
FENOFIBRATE 252 174 18 95
ZOLPIDEM TARTRATE 244 146 19 16
LISINOPRIL-HYDROCHLOROTHIAZIDE 223 148 20 23
ATORVASTATIN CALCIUM 221 149 21 15
NEXIUM 220 125 22 26
PROAIR HFA 219 138 23 38
DONEPEZIL HCL 212 210 24 25
CARVEDILOL 204 192 25 21
CLOPIDOGREL 198 165 26 30
TRAZODONE HCL 196 133 27 32
WARFARIN SODIUM 180 179 28 19
TAMSULOSIN HCL 162 159 29 28
POLYETHYLENE GLYCOL 3350 156 114 30 45
SPIRIVA 155 131 31 53
AZITHROMYCIN 141 112 32 39
ADVAIR DISKUS 136 87 33 43
DIGOXIN 127 118 34 47
ALENDRONATE SODIUM 121 99 35 35
QUETIAPINE FUMARATE 120 101 36 76
PLAVIX 118 95 37 49
RANITIDINE HCL 116 82 38 29
ALLOPURINOL 114 83 39 36
ISOSORBIDE MONONITRATE ER 104 101 40 73
LIPITOR 104 66 40 116
MEGESTROL ACETATE 95 91 R 42 103
NAMENDA 93 93 43 31
DETROL LA 93 62 43 139
LOSARTAN POTASSIUM 91 86 45 34
SYMBICORT 90 57 46 176
CRESTOR 88 58 47 33
FLUTICASONE PROPIONATE 87 48 48 27
PROMETHAZINE HCL 83 51 R 49 69
GLIMEPIRIDE 79 58 50 61
MUPIROCIN 77 73 51 154
JANUVIA 75 49 52 75
GLIPIZIDE 74 54 53 57
CYCLOBENZAPRINE HCL 74 24 R 53 37
VENTOLIN HFA 72 38 55 122
ATENOLOL 71 34 56 22
TERAZOSIN HCL 71 56 56 127
LYRICA 70 47 58 62
LEVEMIR FLEXPEN 67 40 59 178
METHOCARBAMOL 66 27 R 60 159
XOPENEX HFA 65 42 61 283
MIRTAZAPINE 65 65 61 52
VENLAFAXINE HCL ER 61 29 63 105
DIOVAN 57 57 64 51
SOTALOL 54 48 65 294
SERTRALINE HCL 54 42 65 24
METFORMIN HCL ER 54 39 65 84
CEPHALEXIN 53 41 68 89
TRICOR 52 24 69 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 30, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.